Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
207.00    -10.00 (-4.61%)
Bid:
213.00
Ask:
222.00
Spread: 9.00 (4.225%)
Market Cap: £109.29m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Director/PDMR Shareholding

22 Oct 2015 07:01

RNS Number : 0341D
Microgen PLC
22 October 2015
 



22 October 2015

The following share options have been awarded to the following persons discharging managerial responsibilities/directors:

NOTIFICATION OF TRANSACTIONS OF DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with section 793 of the Companies Act 2006, or (iii) in accordance with paragraph 26 of the Model Code

MICROGEN PLC

(i)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

PHILIP WOOD

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

N/A

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

N/A

N/A

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

13.

Price per share or value of transaction

14.

Date and place of transaction

N/A

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

N/A

N/A

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

21 OCTOBER 2015

21 OCTOBER 2018 TO 21 OCTOBER 2025

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

NIL

150,000 ORDINARY SHARES OF 6 3/7 PENCE EACH UNDER THE MICROGEN PERFORMANCE SHARE PLAN 2006

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

6 3/7 PENCE

650,000

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY’S CURRENT ISSUED SHARE CAPITAL WHICH IS 58,060,521

PHILIP WOOD, GROUP FINANCE DIRECTOR, MICROGEN PLC â€" 020 7496 8100

              Â

 

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with section 793 of the Companies Act 2006, or (iii) in accordance with paragraph 26 of the Model Code

MICROGEN PLC

(i)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

SIMON BAINES

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

N/A

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

N/A

N/A

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

13.

Price per share or value of transaction

14.

Date and place of transaction

N/A

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

N/A

N/A

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

21 OCTOBER 2015

21 OCTOBER 2018 TO 21 OCTOBER 2025

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

NIL

150,000 ORDINARY SHARES OF 6 3/7 PENCE EACH UNDER THE MICROGEN PERFORMANCE SHARE PLAN 2006

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

6 3/7 PENCE

650,000

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY’S CURRENT ISSUED SHARE CAPITAL WHICH IS 58,060,521

PHILIP WOOD, GROUP FINANCE DIRECTOR, MICROGEN PLC â€" 020 7496 8100

 

 

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with section 793 of the Companies Act 2006, or (iii) in accordance with paragraph 26 of the Model Code

MICROGEN PLC

(i)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

TOM CRAWFORD

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

N/A

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

N/A

N/A

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

13.

Price per share or value of transaction

14.

Date and place of transaction

N/A

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

N/A

N/A

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

21 OCTOBER 2015

21 OCTOBER 2018 TO 21 OCTOBER 2025

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

NIL

500,000 ORDINARY SHARES OF 6 3/7 P EACH UNDER THE MICROGEN PERFORMANCE SHARE PLAN 2006

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

6 3/7 PENCE

650,000

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY’S CURRENT ISSUED SHARE CAPITAL WHICH IS 58,060,521

PHILIP WOOD, GROUP FINANCE DIRECTOR, MICROGEN PLC â€" 020 7496 8100

 

 

 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with section 793 of the Companies Act 2006, or (iii) in accordance with paragraph 26 of the Model Code

MICROGEN PLC

(i)

3.

Name of person discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

ANJUM O’NEILL

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

N/A

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

N/A

N/A

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

N/A

13.

Price per share or value of transaction

14.

Date and place of transaction

N/A

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

N/A

N/A

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which it can be exercised

21 OCTOBER 2015

21 OCTOBER 2018 TO 21 OCTOBER 2025

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

NIL

25,000 ORDINARY SHARES OF 6 3/7 P EACH UNDER THE MICROGEN PERFORMANCE SHARE PLAN 2006

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

6 3/7 PENCE

125,000

23.

Any additional information

24.

Name of contact and telephone number for queries

INFORMATION IS BASED ON THE COMPANY’S CURRENT ISSUED SHARE CAPITAL WHICH IS 58,060,521

PHILIP WOOD, GROUP FINANCE DIRECTOR, MICROGEN PLC â€" 020 7496 8100

 

Name and signature of duly authorised officer of issuer responsible for making notification

PHILIP WOOD, GROUP FINANCE DIRECTOR, MICROGEN PLC

Date of notification:  22 October 2015

www.microgen.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPGGMGUUPAGQG
Date   Source Headline
18th Oct 201710:37 amRNSHolding(s) in Company
9th Oct 201712:42 pmRNSHolding(s) in Company
2nd Oct 201711:51 amRNSBlock Listing Return
2nd Oct 201711:49 amRNSTotal Voting Rights
25th Sep 20178:39 amRNSHolding(s) in Company
21st Sep 20178:30 amRNSHolding(s) in Company
18th Sep 201712:16 pmRNSHolding(s) in Company
14th Sep 20174:45 pmRNSHolding(s) in Company
13th Sep 201712:05 pmRNSHolding(s) in Company
12th Sep 20178:33 amRNSHolding(s) in Company
7th Sep 20178:00 amRNSHolding(s) in Company
31st Aug 20177:00 amRNSAcquisition of RevStream
18th Aug 20174:36 pmRNSHolding(s) in Company
11th Aug 201710:47 amRNSAward of Options
4th Aug 20179:50 amRNSHolding(s) in Company
25th Jul 20173:50 pmRNSHolding(s) in Company
24th Jul 20171:12 pmRNSHolding(s) in Company
24th Jul 20177:00 amRNSInterim Results
6th Jul 20177:00 amRNSTrading Update and Notice of Results
30th Jun 20172:11 pmRNSTotal Voting Rights
21st Jun 20173:06 pmRNSHolding(s) in Company
2nd Jun 20171:43 pmRNSTotal Voting Rights
1st Jun 20177:00 amRNSHolding(s) in Company
17th May 20177:00 amRNSDirector Declaration
17th May 20177:00 amRNSHolding(s) in Company
12th May 201712:08 pmRNSHolding(s) in Company
9th May 20177:00 amRNSHolding(s) in Company
24th Apr 201712:15 pmRNSResult of AGM
24th Apr 20177:00 amRNSAGM Trading update
11th Apr 20174:09 pmRNSHolding(s) in Company
3rd Apr 20177:00 amRNSBlock listing Interim Review
21st Mar 201712:51 pmRNSHolding(s) in Company
17th Mar 201711:22 amRNSHolding(s) in Company
16th Mar 20174:31 pmRNSDirector/PDMR Shareholding
14th Mar 20174:32 pmRNSHolding(s) in Company
9th Mar 20174:38 pmRNSHolding(s) in Company
8th Mar 20177:00 amRNSAudited Preliminary Results
28th Feb 20177:00 amRNSDirectorate Change
27th Feb 20177:00 amRNSAcquisition of Primacy Corporation
6th Feb 20173:39 pmRNSHolding(s) in Company
3rd Feb 20175:22 pmRNSHolding(s) in Company
1st Feb 20172:24 pmRNSTotal Voting Rights
25th Jan 20177:00 amRNSNotice of Results and Business Update
21st Dec 20163:51 pmRNSDirector/PDMR Shareholding
17th Nov 201610:50 amRNSBlock Listing Application
10th Oct 20169:37 amRNSBlock listing Interim Review
3rd Oct 20169:45 amRNSTotal Voting Rights
4th Aug 20167:00 amRNSDirector/PDMR Shareholding
29th Jul 201612:41 pmRNSHolding(s) in Company
29th Jul 201612:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.